# Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage

> **NCT04857632** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 98 (estimated)

## Conditions studied

- Intracerebral Hemorrhage
- Statins

## Interventions

- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT04857632
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-06
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04857632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04857632, "Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04857632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*